Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 2
2007 3
2008 2
2009 1
2010 1
2011 2
2012 1
2013 3
2014 5
2015 5
2016 9
2017 10
2018 15
2019 26
2020 24
2021 15
2022 27
2023 26
2024 17
2025 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Results by year

Filters applied: . Clear all
Page 1
Kefir: a powerful probiotics with anticancer properties.
Sharifi M, Moridnia A, Mortazavi D, Salehi M, Bagheri M, Sheikhi A. Sharifi M, et al. Among authors: sheikhi a. Med Oncol. 2017 Sep 27;34(11):183. doi: 10.1007/s12032-017-1044-9. Med Oncol. 2017. PMID: 28956261 Review.
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. CRASH-2 trial collaborators, et al. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14. Lancet. 2010. PMID: 20554319 Clinical Trial.
Advancing Frontiers in Bone Bioprinting.
Ashammakhi N, Hasan A, Kaarela O, Byambaa B, Sheikhi A, Gaharwar AK, Khademhosseini A. Ashammakhi N, et al. Among authors: sheikhi a. Adv Healthc Mater. 2019 Apr;8(7):e1801048. doi: 10.1002/adhm.201801048. Epub 2019 Feb 8. Adv Healthc Mater. 2019. PMID: 30734530 Review.
Minimally Invasive and Regenerative Therapeutics.
Ashammakhi N, Ahadian S, Darabi MA, El Tahchi M, Lee J, Suthiwanich K, Sheikhi A, Dokmeci MR, Oklu R, Khademhosseini A. Ashammakhi N, et al. Among authors: sheikhi a. Adv Mater. 2019 Jan;31(1):e1804041. doi: 10.1002/adma.201804041. Epub 2018 Nov 22. Adv Mater. 2019. PMID: 30565732 Free PMC article. Review.
A review of trafficking and activation of uterine natural killer cells.
van den Heuvel MJ, Xie X, Tayade C, Peralta C, Fang Y, Leonard S, Paffaro VA Jr, Sheikhi AK, Murrant C, Croy BA. van den Heuvel MJ, et al. Among authors: sheikhi ak. Am J Reprod Immunol. 2005 Dec;54(6):322-31. doi: 10.1111/j.1600-0897.2005.00336.x. Am J Reprod Immunol. 2005. PMID: 16305657 Free PMC article. Review.
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F, Börjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kálmán J, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Frisoni G, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, de la Sayette V, Sénéchal O, Lavenu I, Devendeville A, Calais G, Crawford F, Mullan M; NILVAD Study Group. Lawlor B, et al. Among authors: sheikhi a. PLoS Med. 2018 Sep 24;15(9):e1002660. doi: 10.1371/journal.pmed.1002660. eCollection 2018 Sep. PLoS Med. 2018. PMID: 30248105 Free PMC article. Clinical Trial.
184 results